Cargando…

Understanding the role of CD44V6 in ovarian cancer

This study examined the association of CD44V6 expression in ovarian cancer. We recruited 38 patients with ovarian cancer, 23 with benign ovarian tumor, and 20 with normal ovaries using RT-PCR and western block analysis. Compared with normal ovaries, the expression of CD44V6 mRNA was significantly el...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hui-Feng, Hu, Peng, Fang, Sheng-Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530090/ https://www.ncbi.nlm.nih.gov/pubmed/28789431 http://dx.doi.org/10.3892/ol.2017.6377

Ejemplares similares

Correlation of CD44v6 expression with ovarian cancer progression and recurrence
por: Shi, Jun, et al.
Publicado: (2013)

Retraction Note: Correlation of CD44v6 expression with ovarian cancer progression and recurrence
por: Shi, Jun, et al.
Publicado: (2020)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
por: Ween, Miranda P., et al.
Publicado: (2011)

Expression of CD44v6 and Its Association with Prognosis in Epithelial Ovarian Carcinomas
por: Zhou, Dang-xia, et al.
Publicado: (2012)

CD44v6 engages in colorectal cancer progression
por: Ma, Lixin, et al.
Publicado: (2019)

CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
por: Wang, Zhe, et al.
Publicado: (2018)

Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer
por: Hu, Bangli, et al.
Publicado: (2015)

CD44v6 may influence ovarian cancer cell invasion and migration by regulating the NF-κB pathway
por: Wang, Yanqing, et al.
Publicado: (2019)

CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation
por: Guo, Qian, et al.
Publicado: (2021)

Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
por: Chaudhry, Gul-e-Saba, et al.
Publicado: (2021)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014)

Promotion of ovarian cancer cell invasion, migration and colony formation by the miR-21/Wnt/CD44v6 pathway
por: Wang, Yanqing, et al.
Publicado: (2019)

CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3
por: Martincuks, Antons, et al.
Publicado: (2020)

Diagnostic accuracy of CD44V6 for osteosarcoma: a meta-analysis
por: Zhang, Yunyuan, et al.
Publicado: (2016)

Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
por: Lin, Z., et al.
Publicado: (2001)

Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer
por: Wu, Cheng-Lin, et al.
Publicado: (2015)

Prognostic value of CD44v6 expression in breast cancer: a meta-analysis
por: Qiao, Guang-Lei, et al.
Publicado: (2018)

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis
por: Sosulski, Amanda, et al.
Publicado: (2016)

miR-21 Induces Chemoresistance in Ovarian Cancer Cells via Mediating the Expression and Interaction of CD44v6 and P-gp
por: Wang, Yanqing, et al.
Publicado: (2021)

The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis
por: Lin, Jiaying, et al.
Publicado: (2017)

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022)

Expression and Function of CD44 in Epithelial Ovarian Carcinoma
por: Sacks, Joelle D., et al.
Publicado: (2015)

CD44v6-O-MWNTS-Loaded Gemcitabine and CXCR4 siRNA Improves the Anti-tumor Effectiveness of Ovarian Cancer
por: Yin, Wen, et al.
Publicado: (2021)

CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
por: Tjhay, Francisca, et al.
Publicado: (2015)

Targeting aggressive prostate cancer-associated CD44v6 using phage display selected peptides
por: Peng, Ying, et al.
Publicado: (2017)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
por: Montero-Montero, Lucía, et al.
Publicado: (2020)

Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer
por: Gao, Yan, et al.
Publicado: (2015)

CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis
por: Wang, Ji-Lin, et al.
Publicado: (2016)

Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers
por: Haylock, Anna-Karin, et al.
Publicado: (2017)

CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells
por: Li, Linxian, et al.
Publicado: (2016)

SFPQ Promotes Lung Cancer Malignancy via Regulation of CD44 v6 Expression
por: Yang, Libang, et al.
Publicado: (2022)

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
por: Sliutz, G., et al.
Publicado: (1995)

MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
por: Vos, Maria Caroline, et al.
Publicado: (2016)

Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study
por: Matuschek, Christiane, et al.
Publicado: (2014)

Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma
por: Gun, Banu Dogan, et al.
Publicado: (2012)

Rosiglitazone amplifies the sensitivity of docetaxel and reduces the expression of CD44v6
por: JI, FAHE, et al.
Publicado: (2014)

Identification of novel CD44v6-binding peptides that block CD44v6 and deliver a pro-apoptotic peptide to tumors to inhibit tumor growth and metastasis in mice
por: Khan, Fatima, et al.
Publicado: (2021)

High Expression of Lewis y Antigen and CD44 Is Correlated with Resistance to Chemotherapy in Epithelial Ovarian Cancers
por: Hu, Zhenhua, et al.
Publicado: (2013)

Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis
por: Zhang, Yunyuan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0e1pisbsl7gfgq2kgp2omimlio